 The use of 18F, DCFPYL Positron Emission Tomography, PET, computed tomography, CT, for prostate cancer staging is more effective than traditional methods such as multi-parametric magnetic resonance imaging, MRI, computed tomography, CT, of the chest, abdomen, and pelvis, and whole body bone scan. Additionally, 18F, DCFPYL Peru Time Slash Central Time is more sensitive and specific than other prostate specific imaging modalities, making it a better option for diagnosing prostate cancer. However, access to this technology is not equitable across different populations, which could lead to disparate outcomes in patient care. To address this issue, the distribution network of the radio tracer must include both academic and non-academic sites nationwide. This article was offered by Kritika Subramanian, Wana Matinas, Sandra Huycochia Costionos, and others.